期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

ProEx C在宫颈癌及其癌前病变中的表达及意义

Expression and Significance of ProEx C in Cervical Cancer and Cervical Intraepithelial Noplasia
原文传递
导出
摘要 目的:探讨ProEx C在宫颈癌及其癌前病变中的表达及意义。方法:应用免疫组织化学SP法检测ProEx C在不同宫颈病变组织芯片中的表达。结果:ProEx C在宫颈炎、CINI、CINII、CINIII及宫颈癌中的阳性表达率分别是25%,51.7%,77.9%,90%,93.8%,且其表达在宫颈癌及CINIII级病变与宫颈炎及CINI级病变相比较差异具有统计学意义(P<0.05),ProEx C在CINI级组织中表达低于CINII级,差异具有统计学意义(P<0.05),ProEx C在浸润性宫颈癌中的表达与临床病理因素无关(P>0.05)。结论:ProEx C反映了细胞的增殖活性,促进宫颈癌的发生发展,可作为诊断及监测预后的指标。 Objective： To explore the expression and significance of ProEx C in cervical cancer and cervical intraepithelial neoplasia. Methods： The expressions of ProEx C in the cervical tissue microarray were detected by immunohistochemical SP methods. Results：The positive rate of ProEx C in chronic cervicitis, CINⅠ, CINⅡ, CINⅢ and cervical cancer were 25%,51.7%, 77.9%, 90%, 93.8% respectively. The expression levels of ProEx C in cervical cancer and CINⅢ were significantly higher than those in cervicitis and CINI tissues （P〈0.05）. ProEx C expression was higher in CINⅡ lesions than in CINⅠ lesions（P〈0.05 ）.There were no significant differences between ProEx C expressions and clinicopathologic factors （P〉0.05）. Conclusions： The expression ofProEx C reflect the proliferative activity and it play an important role in the carcinogenesis of cervical cancer. Moreover it could be useful in diagnosing the degree of cervical lesions and monitoring the prognosis.
作者 张蕾 王霞 张珊 杨彦华 石纳玉 蔡广彦
机构地区 青岛大学医学院 青岛市市立医院 青岛市第八人民医院
出处 《现代生物医学进展》 CAS 2011年第20期3878-3881,共4页 Progress in Modern Biomedicine
关键词 子宫颈癌 子宫颈癌前病变 ProEx C组织芯片 免疫组化 Cervical cancer Cervical intraepithelial neoplasia ProEx C Tissue microarray
分类号 R737.33 [医药卫生—肿瘤]
  • 相关文献

参考文献16

  • 1Gakiopoulou H, Korkolopoulou P, Levidou G, et al. Minichromosome maintenance proteins and in non - benign epithelial ovarian tumors : relationship with cell cycle regulators and prognostic implications[J]. Br J Cancer, 2007,97 (8) : 1124 - 1134.
  • 2Ho GYH, Bierman R, Beardsley L, et al. Nature history of cervicova- ginal papillomavirus infection as measured by repeated DNA testing in adolescent and young women[J]. N Engl J Med, 1998,338 : 423 - 428.
  • 3Malinowski DP. Molecular diagnostic assays for cervical neoplasia: emerging markers for the detection of high-grade cervical disease[J]. Biotechniques, 2005,(suppl): 17-23.
  • 4Murphy N, Ring M, Heffron CC, et al. Quantitation of CDC6 and MC- M5 mRNA in cervical intraepithelial neoplasia and invasive squamo- us cell carcinoma of the cervix[J]. Mod Pathol. 2005, 18:844-849.
  • 5Murphy N, Ring M, Heffron CC, et al. p16INK4A, CDC6,and MCM5: predictive biomarkers in cervical preinvasive neoplasia and cervical cancer[J]. J Clin Pathol. 2005;58:525-534.
  • 6Beccati MD, Buriani C, Pedriali M, et al. Quantitative Detection of Molecular Markers ProEx C(Minichromosome Maintenance Protein 2 andTopoisomerase Ⅱa) and MIB-1 in Liquid-basedCervical Squamous Cell Cytology[J].Cancer. 2008,114(3): 196-203.
  • 7Poplawski A ,Grabowski B ,Long S E ,et al. The zinc finger domain of the arehaeal miniehromosome maintenance protein is required for heliease activity[J]. Biol Chem ,2001,276 (52) : 49 371 - 49 377.
  • 8You Z, Ishimi Y, Masai H ,et al. Roles of Mcm7 and Mcm4 subunitsin the DNA helicase activity of the mouse Mem4/6/7 complex [J] . BiolChem, 2002, 277 (45) : 42471- 42479.
  • 9Sterner J, Dew - Knight S, Musahl C ,et al. Negative regulation of D- NA replication by the retinoblastoma protein Is mediated by its assoc- iation with MCM7[J]. Mol Cell Biol,1998,18 (5): 2748-2757.
  • 10Sington J D , Freeman A , Moils L S ,et al. Minichromosome maintenance protein in myxofibrosarcoma [J]. Mod Pathol,2004,17 (2) :235 - 240.

二级参考文献9

  • 1Burger PC, Shibata T, Kleihues P. The use of the monoclonal antibody Ki-67 in the identification of proliferating cells: application to surgical neuropathology[J]. Am J Surg Pathol, 1986,10 (9) : 611-617.
  • 2Ostertag CB, Volk B, Shibata T, et al. The monoclonal antibody Ki-67 as a marker for proliferating cells in stereotactic biopsies of brain tumours[J]. Acta Neurochir (Wien), 1987,89(3-4):117-121.
  • 3Shibata T, Burger PC, Kleihues P. Ki-67 immunoperoxidase stain as marker for the histological grading of nervous system tumours[J]. Acta Neurochir Suppl (Wien), 1988, 43:103-106.
  • 4Patsouris E, Stocker U, Kallmeyer V, et al. Relationship between Ki-67 positive cells, growth rate and histological type of human intracranial tumors [J]. Anticancer Res, 1988,8(4):537-544.
  • 5Demeule M, Shedid D, Beaulieu E, et al. Expression of multidrug-resistance P-glycoprotein ( MDR1 ) in human brain tumors[J]. Int J Cancer,2001,93(1):62-66.
  • 6Abe T, Mori T, Wakabayashi Y, et al. Expression of mul tidrug resistance protein gene in patients with glioma after chemotherapy[J]. J Neurooncol,1998,40(1):11-18.
  • 7von Bossanyi P, Diete S, Dietzmann K, et al. Immunohistochemical expression of P-glycoprotein and glutathione Stransferases in cerebral gliomas and response to chemotherapy[J]. Acta Neuropathol (Berl),1997,94(6):605-611.
  • 8Taniguchi K, Wakabayashi T, Yoshida T, et al. Immuno histochemical staining of DNA topoisomerase Ⅱ alpha in human gliomas[J]. J Neurosurg,1999,91(3):477-482.
  • 9Miettinen HE, Jarvinen TA, Kellner U, et al. High topoisomerase Ⅱ alpha expression associates with high proliferation rate and poor prognosis in oligodendrogliomas[J]. Neuropathol Appl Neurobiol,2000,26(6) :504-512.

共引文献2

现代生物医学进展
2011年 第20期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部